Established and headquartered in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a leading biotechnology company that combines regional advantages in Singapore, China and Germany, to cover the entire value chain from innovative drug research and discovery, manufacturing, clinical development and commercialization.
SCG specializes in the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, human papillomavirus, and hepatitis B, and develops a broad and unique pipeline of T cell therapies, antibodies, and therapeutic vaccines against infections and to prevent and cure its associated cancers.
SCG collaborates with leading scientists and researchers to bring first-in-class medical products/technologies to enhance innovation in medical product development.
Company Details
- Employees
- 27
- Founded
- -
- Address
- Singapore, Singapore, Sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.scgcell.com
- Keywords
- Cell Therapy, Bispecific Antibody, Immunotherapy, Scientific Research, Therapeutic Vaccine, Drug Product, Medical Product, Medical Technologies, Cancer Prevention, Cancer Therapy, COVID-19 Drug, Drug Research and Discovery.
- HQ
- Singapore, Singapore
Scg Cell Therapy Questions
Scg Cell Therapy's website is http://www.scgcell.com
Scg Cell Therapy's LinkedIn profile is https://sg.linkedin.com/company/scgcell
Scg Cell Therapy has
27 employees.
View email and phone details for 27
employees at Scg Cell Therapy.
Scg Cell Therapy's industry is
Biotechnology Research
Scg Cell Therapy's top competitors are
Tessa Therapeutics Ltd,
Biosyngen,
Sensorion,
Veongen Therapeutics Gmbh,
Hummingbird Bioscience,
Aurion Biotech,
Gemma Biotherapeutics,
Tikva Allocell Pte Ltd,
Pepromene Bio,
A*star - Agency For Science, Technology And Research.
Scg Cell Therapy's categories are Biotechnology Research
Scg Cell Therapy's founding year is 2017
